MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-19-0023566
General Drug Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹50.21 Cr
▲ 6% YoY
Net profit · FY 2025
₹2.52 Lakh
Net margin 0.1%
EBITDA · FY 2025
₹72.26 Lakh
EBITDA margin 1.4%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹12.27 Cr
Satisfied ₹75 Lakh
Company age
18 yrs
Est. 2008
Employees · EPFO
22
Provident fund records
About General Drug Private Limited
Data last updated:
General Drug Private Limited is a private limited company based in Mumbai, Maharashtra, India, a subsidiary of Doshi Medicare Private Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 April 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24232MH2008PTC181102. Its GSTIN is 27AADCG3413H1ZW (Maharashtra).
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Mukesh Mahendrakumar Doshi and Hitesh Doshi Mukeshkumar.
Its last annual general meeting (AGM) was held on 28 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Hira House 1st Floor 381 – 383 S.V.P. Road Near Lilavati School, Mumbai, Maharashtra, India – 400004.
As per the financials filed for FY 2025, the company reported a revenue of ₹50.21 Cr, a growth of 6% compared to the previous year. For the same year it recorded a net profit of ₹2.52 Lakh (net margin 0.1%) and EBITDA of ₹72.26 Lakh (EBITDA margin 1.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 1% over five years.
The company has about 22 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.27 Cr and satisfied charges of ₹75 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company.
General Drug Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0023566). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dbpharma.in.
Company details
CIN U24232MH2008PTC181102
Registration Number 181102
Incorporation Date 15 April 2008
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 28 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Doshi Medicare Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-19-0023566
Key People
Mukesh Mahendrakumar Doshi Director Hitesh Doshi Mukeshkumar Director Yogesh Mukeshkumar Doshi Director Recognitions & Rankings of General Drug
Contact details
General Drug Private Limited's registered office is in Mumbai, Maharashtra. Its website is dbpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressHira House 1st Floor 381 – 383 S.V.P. Road Near Lilavati School, Mumbai, Maharashtra, India – 400004
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of General Drug Private Limited, buy the company report.
Comprehensive company report
General Drug Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of General Drug is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of General Drug Private Limited, buy the company report.
Financials of General Drug Private Limited
FY 2024 filings availableGeneral Drug Private Limited reported revenue of ₹50.21 Cr (up 6% YoY) for FY 2025.
Revenue · FY 2025
₹50.21 Cr ▲ 6%
Net profit · FY 2025
₹2.52 Lakh margin 0.1%
EBITDA · FY 2025
₹72.26 Lakh margin 1.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 6%
5 years · compounded
▲ 1%
EBITDA CAGR growth
1 year
▼ 5%
3 years · compounded
▲ 3%
5 years · compounded
▼ 3%
Revenue has grown at a compounded annual rate (CAGR) of 1% over five years, including 6% growth in the latest year. EBITDA fell 5% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹72.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.52 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.4% | ||||
| Net Profit Margin | 0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of General Drug Private Limited, buy the company report.
Board of directors of General Drug Private Limited
General Drug has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Mahendrakumar Doshi Also directs: S. Himatlal Healthcare LLP, Paramm's Interglobal LLP, N Chimanlal and Co Private Limited and 2 more | Director | 11 Oct 2009 | 17 Years 0 Months | Current |
| Hitesh Doshi Mukeshkumar Also directs: N Chimanlal and Co Private Limited, Doshi Medicare Private Limited, Doshi Mediventures Private Limited and 3 more | Director | 11 Oct 2009 | 17 Years 0 Months | Current |
| Yogesh Mukeshkumar Doshi Also directs: S. Himatlal Healthcare LLP, N Chimanlal and Co Private Limited, Doshi Medicare Private Limited and 3 more | Director | 11 Oct 2009 | 17 Years 0 Months | Current |
Peer comparison
General Drug Private Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nectar Drugs Private Limited | ₹50.75 Cr (FY 2025) | -17.0% | Mumbai, Maharashtra, India | |||
| SG Pharma Distributors Private Limited | ₹50.62 Cr (FY 2024) | 22.0% | Delhi, India | |||
| Banmala Commercial Pvt.Ltd. | ₹50.58 Cr (FY 2024) | 10.0% | 24Pgs North, West Bengal, India | |||
| Uni Agencies Chemicals Private Ltd | ₹50.45 Cr (FY 2024) | -4.0% | New Delhi, Delhi, India | |||
| General Drug Private Limitedthis company | ₹50.21 Cr (FY 2025) | ₹2.52 Lakh | 0.1% | 6.0% | 22 | Mumbai, Maharashtra, India |
| Murli Krishna Exports Private Limited | ₹50.2 Cr (FY 2025) | 58.0% | Mumbai, Maharashtra, India | |||
| Viraj Pharmaceuticals Private Limited | ₹50.17 Cr (FY 2025) | -4.0% | Mumbai, Maharashtra, India | |||
| Hexacare Pharmaceuticals Private Limited | ₹50.05 Cr (FY 2025) | 18.0% | Chennai, Tamil Nadu, India | |||
| Veritas Life Sciences Limited | ₹50.05 Cr (FY 2025) | 45.0% | Narela, Delhi, India | |||
| Sapna Pharmaceuticals Private Limited | ₹49.88 Cr (FY 2024) | 69.0% | Bangalore, Karnataka, India |
To see the full peer comparison of General Drug Private Limited, buy the company report.
Auditor
General Drug Private Limited is audited by RAJNIKANT VRAJLAL SHAH for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAJNIKANT VRAJLAL SHAH | FY 2023 | 016990 |
Shareholding
The shareholding of General Drug Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of General Drug Private Limited, buy the company report.
Charges & borrowings
Open charges
₹12.27 Cr
Satisfied charges
₹75 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 Dec 2019 | 100314450 | Hdfc Bank Limited | ₹6.85 Cr | Open | |
| 27 Nov 2010 | 10258688 | Kotak Mahindra Bank Limited | ₹5.43 Cr | Open | |
| 20 May 2010 | 10223266 | Kotak Mahindra Bank Limited | ₹75 Lakh | Satisfied |
To see the full charge records of General Drug Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
General Drug Private Limited has 1 court case on record: 1 filed by General Drug. All case is disposed.
Total cases
1
Filed by the company
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS WARRENT CASES SW) | Filed by the company against Baun Foundation Trust and 2 others | Disposed |
To see the full case history of General Drug Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for General Drug Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
General Drug Private Limited has a workforce of 22 employees on its EPFO records as of Mar 28, 2024, across 1 active EPFO establishment.
Employee count
22
Active EPFO establishments
1
GST
General Drug has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCG3413H1ZW | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of General Drug Private Limited, buy the company report.
Recent activity
General Drug Private Limited has 6 board changes on record since 2009: 3 appointments and 3 cessations. The latest: Dhiren Mahendra Ashar ceased to be Director on 11 Nov 2009.
Charges
A charge with Hdfc Bank Limited of Rs. 684.87 Lakh registered on 20 Dec 2019 with Charge ID 100314450 was modified on 31 Jan 2025.
AGM
General Drug Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records.
Filing
General Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 684.87 Lakh with Charge ID 100314450 was registered on 20 Dec 2019.
Charges
A charge with Kotak Mahindra Bank Limited of Rs. 542.50 Lakh registered on 27 Nov 2010 with Charge ID 10258688 was modified on 10 Mar 2015.
Charges
A charge registered on 20 May 2010 via Charge ID 10223266 with Kotak Mahindra Bank Limited was fully satisfied on 19 Jan 2011.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 542.50 Lakh with Charge ID 10258688 was registered on 27 Nov 2010.
Charges
A charge with Kotak Mahindra Bank Limited amounted to Rs. 75.00 Lakh with Charge ID 10223266 was registered on 20 May 2010.
Ceased
Dhiren Mahendra Ashar ceased to be Director.
Ceased
Mahendra Chatrabhuj Ashar ceased to be Director.
Ceased
Mahendra Chatrabhuj Ashar ceased to be Director.
Appointed
Hitesh Doshi Mukeshkumar was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
General Drug is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 April 2008 (18+ years old) and is registered under CIN U24232MH2008PTC181102.
General Drug has 3 current directors:
- Mukesh Mahendrakumar Doshi - Director
- Hitesh Doshi Mukeshkumar - Director
- Yogesh Mukeshkumar Doshi - Director
The latest financial statements of General Drug on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 28 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of General Drug is 27AADCG3413H1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of General Drug is U24232MH2008PTC181102. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
General Drug has 1 court case on record: 1 filed by the company.
General Drug was incorporated on 15 April 2008, making it 18+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of General Drug by revenue are Nectar Drugs Private Limited, SG Pharma Distributors Private Limited, Banmala Commercial Pvt.Ltd, Uni Agencies Chemicals Private Ltd, Murli Krishna Exports Private Limited and 4 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Dhiren Mahendra Ashar ceased to be Director on 11 Nov 2009. Mahendra Chatrabhuj Ashar ceased to be Director on 11 Nov 2009. Mahendra Chatrabhuj Ashar ceased to be Director on 11 Nov 2009. General Drug has 6 board changes on record in total.
Yes, General Drug is registered as a small enterprise under Udyam registration (number: UDYAM-MH-19-0023566).
General Drug can be reached through the website dbpharma.in. Its registered office is in Mumbai, Maharashtra, India.